Australia Markets closed
  • ALL ORDS

    7,137.60
    -11.00 (-0.15%)
     
  • ASX 200

    6,955.20
    -13.40 (-0.19%)
     
  • AUD/USD

    0.6644
    -0.0048 (-0.7142%)
     
  • OIL

    68.02
    -1.94 (-2.77%)
     
  • GOLD

    1,999.50
    +3.60 (+0.18%)
     
  • BTC-AUD

    42,105.19
    +808.86 (+1.96%)
     
  • CMC Crypto 200

    606.59
    -11.80 (-1.91%)
     
  • AUD/EUR

    0.6172
    +0.0002 (+0.03%)
     
  • AUD/NZD

    1.0712
    +0.0016 (+0.15%)
     
  • NZX 50

    11,580.81
    -14.13 (-0.12%)
     
  • NASDAQ

    12,697.87
    -31.37 (-0.25%)
     
  • FTSE

    7,392.09
    -107.51 (-1.43%)
     
  • Dow Jones

    31,929.91
    -175.34 (-0.55%)
     
  • DAX

    14,917.86
    -292.53 (-1.92%)
     
  • Hang Seng

    19,915.68
    -133.96 (-0.67%)
     
  • NIKKEI 225

    27,385.25
    -34.36 (-0.13%)
     

Is Biogen Stock a Buy Now?

Is Biogen Stock a Buy Now?

Moving new medicines to the market can sometimes make biopharmaceutical companies tons of returns. Biogen (NASDAQ: BIIB) just scored a major new drug approval for an Alzheimer's disease therapy, so investors are understandably rushing to evaluate whether to buy the stock. One key factor that could drive Biogen's outperformance in the next few years is the launch of a new neurology medicine.